Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared a post on X:
“Presentation 5 on last day of AHA 2025 by Sarah Malik of Duke University’s Department of Medicine from Medical College of Georgia!
Take home – In 12,832 ARIC participants followed for 28 years, 877 cancer survivors and 3,653 non-cancer participants developed incident CVD.
Across both unmatched and propensity-matched analyses, the use of statins, anti-hypertensives, and aspirin was consistently associated with lower CVD risk in both cancer and non-cancer groups.
The magnitude of benefit was comparable between groups, indicating that cancer survivors derive similar cardiovascular protection from these preventive medications as individuals without cancer.”
More posts on AHA25.
